Moderator: Wellington K. Hsu, MD
3:40 – 3:44 p.m.
Introduction by Section Chair, Wellington K. Hsu, MD
3:44 – 3:50 p.m.
Section on Biologics and Basic Research Best Paper
98. Characterization, Imaging and Treatment of a Mouse Model of Human Spinal Cancer
Presenter: Davina Cossigny, PhD
3:50 – 3:56 p.m.
99. Complications and Cancer Rates in Spine Fusion With Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)
Presenter: Alexander T. Mameghani, MD
3:56 – 4:02 p.m.
100. Effect of a Selective Estrogen Receptor Modulator on Bone Formation in Osteoporotic Spine Fusion Using an Ovariectomized Rat Model
Presenter: Sung Bae Park, MD, PhD
4:02 – 4:08 p.m.
101. An Investigational Study of a Novel Parathyroid Hormone-Based Bone Graft Substitute for Interbody Spinal Fusion: An In Vivo Ovine Model
Presenter: Bryan W. Cunningham, PhD
4:08 – 4:14 p.m.
102. Notochordal Cell-Based Therapeutics Regenerate the Degenerative Disc: Evidence in a Pre-Clinical Animal Model of Disc Disease
Presenter: William Mark Erwin, DC, PhD
4:14 – 4:20 p.m.
103. Interrelationships of Vitamin D Status, Bone Health and Fusion Consolidation
Presenter: Neil Bhamb, MD
4:20 – 4:26 p.m.
104. Effect of rhBMP-2 on Lung Cancer Spine Metastasis in Rodents
Presenter: Ralph Cook
4:26 – 4:32 p.m.
105. Expression of Survivin and VEGF in Sacral Chordoma Provides Potential Targets for Therapy
Presenter: Xiaochen Liu
4:32 – 4:38 p.m.
106. Dioxin Exposure Inhibits Osteogenic Differentiation and Impairs Bone Healing in a Rat Spine Fusion Model
Presenter: Ryan Freshman
4:38 – 5:10 p.m.
Discussion